Cargando…
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease
Transforming growth factor beta (TGF-β) is deeply involved on the pathogenesis of Chagas disease. Our group has been investigating the participation of this pleiotropic cytokine in different aspects of Chagas disease over the last 20 years. Important observations have been made, such as: (i) the abi...
Autores principales: | Waghabi, Mariana Caldas, Ferreira, Roberto Rodrigues, Abreu, Rayane da Silva, Degrave, Wim, de Souza, Elen Mello, Bailly, Sabine, Feige, Jean-Jacques, de Araújo-Jorge, Tania C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896758/ https://www.ncbi.nlm.nih.gov/pubmed/35239842 http://dx.doi.org/10.1590/0074-02760210395 |
Ejemplares similares
-
In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022) -
Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
por: de Oliveira, Fabiane L., et al.
Publicado: (2012) -
TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019) -
The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022) -
Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion
por: Ferrão, Patrícia Mello, et al.
Publicado: (2015)